J. Scott Wolchko
Officer, Fate Therapeutics.
Companies
- Fate TherapeuticsBoard member Jan 14, 2016 to Feb 2, 20241
- Fate TherapeuticsChief executive officer Jan 14, 2016 to Feb 2, 20241
- Fate TherapeuticsPresident Jan 14, 2016 to Feb 2, 20241
- Fate TherapeuticsChief financial officer Oct 16, 2015 to Oct 16, 20152
- Fate TherapeuticsChief operating officer Oct 16, 2015 to Oct 16, 20152
- Fate TherapeuticsOfficer Sep 30, 2013 to Apr 14, 20153
Holdings
Stock this person has reported owning, from the forms officers and directors file with the SEC. See the biggest insider stakes.
Shares held
- Fate Therapeutics FATE371,248 shares4$697.9K at $1.88Jan 9, 2024
As of each latest filing. The line shows shares held over time.
Recent filings
- Jan 9, 2024Sold 14,391 shares at $4.37 of Fate Therapeutics4
- Jan 10, 2023Sold 45,907 shares at $5.24 of Fate Therapeutics5
- Jul 22, 2022Sold 620 shares at $33.28 of Fate Therapeutics6
- Jul 22, 2022Sold 2,703 shares at $32.61 of Fate Therapeutics6
- Jul 22, 2022Sold 2,923 shares at $31.33 of Fate Therapeutics6
- Jul 22, 2022Exercised options 6,246 shares at $2.70 of Fate Therapeutics6
- Jul 21, 2022Sold 19,171 shares at $33.07 of Fate Therapeutics6
- Jul 21, 2022Sold 10,829 shares at $32.54 of Fate Therapeutics6
- Jul 21, 2022Exercised options 30,000 shares at $2.70 of Fate Therapeutics6
- Apr 22, 2022Sold 838 shares at $35.15 of Fate Therapeutics7
- Apr 22, 2022Sold 9,162 shares at $34.54 of Fate Therapeutics7
- Apr 22, 2022Exercised options 10,000 shares at $2.70 of Fate Therapeutics7
- Apr 21, 2022Sold 1,003 shares at $37.90 of Fate Therapeutics7
- Apr 21, 2022Sold 2,220 shares at $36.70 of Fate Therapeutics7
- Apr 21, 2022Sold 4,062 shares at $35.73 of Fate Therapeutics7
- Apr 21, 2022Sold 22,715 shares at $34.57 of Fate Therapeutics7
- Apr 21, 2022Exercised options 30,000 shares at $2.70 of Fate Therapeutics7
- Jan 21, 2022Sold 10,000 shares at $38.02 of Fate Therapeutics8
- Jan 21, 2022Exercised options 10,000 shares at $2.70 of Fate Therapeutics8
- Jan 20, 2022Sold 30,000 shares at $40.21 of Fate Therapeutics8
- Jan 20, 2022Exercised options 30,000 shares at $2.70 of Fate Therapeutics9
- Jan 20, 2022Exercised options 30,000 shares at $2.73 of Fate Therapeutics8
- Jan 11, 2022Sold 4,519 shares at $49.07 of Fate Therapeutics10
- Jan 11, 2022Sold 10,047 shares at $48.50 of Fate Therapeutics10
- Jan 10, 2022Sold 101 shares at $47.72 of Fate Therapeutics11
Sources
The numbers on this page point here. Each one links to the record it came from.
- 1SEC EDGARFate Therapeutics, Board member
- 2
- 3SEC EDGARFate Therapeutics, Officer
- 4
- 5SEC EDGARForm 4 filed Jan 11, 2023
- 6SEC EDGARForm 4 filed Jul 25, 2022
- 7SEC EDGARForm 4 filed Apr 25, 2022
- 8SEC EDGARForm 4 filed Jan 24, 2022
- 9SEC EDGARForm 4 filed Feb 4, 2022
- 10SEC EDGARForm 4 filed Jan 13, 2022
- 11SEC EDGARForm 4 filed Jan 12, 2022